NCT03231995View on ClinicalTrials.gov

Biomarkers for the Prognosis of Influenza in Children

NACompletedINTERVENTIONAL

Enrollment

145

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

April 20, 2022

Study Completion Date

April 20, 2022

Conditions

Influenza

Interventions

BIOLOGICAL

Collection of nasopharyngeal specimen collected at D0, D1, D2 and D5.

"Analyses will be performed on nasopharyngeal specimen collected at D0, D1, D2 and D5.~Definition and validation of nasopharyngeal microbiome biomarkers (bacterial, viral, transcriptomic signature)"

Trial Locations (2)

69317

CIC groupement Hospitalier Est - Hospices Civils de Lyon, Lyon

Unknown

Hopital Nord, Saint-Etienne

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT03231995 - Biomarkers for the Prognosis of Influenza in Children | Biotech Hunter | Biotech Hunter